New approaches to tackling antibiotic resistance
By Cameron Lang
The threat of antibiotic resistance is troubling. Recent UK government reports estimate that by 2050 if new antibiotics are not found, drug-resistant infections will kill 10 million people a year and cost the worldwide economy 100 trillion dollars. With the recent discovery of a patient with an E. Coli strand resistant to the ‘last resort’ antibiotic colistin, many are concerned with their future.
Jeremy Hunt, Secretary of State for Health said “Antimicrobial resistance is perhaps our biggest global health threat – it could nullify the progress of over a century of modern medicine.” So what exactly is being done to rebuild the arsenal against resistant infectious diseases?
The first approach involves disrupting bacterial cell-to-cell communication – called quorum sensing. The communication is possible because bacteria can produce, release and detect chemical signals – called signaling molecules. If there are few bacteria in the area, the concentration of signaling molecules is low, so certain genes are prevented from being expressed and the bacteria divide as much as possible. However, once there are enough bacteria in the local area – these signaling molecules cause the bacteria to produce new proteins that allow more effective infection of human cells. New treatments involving disrupting this communication – with many pharmaceutical companies developing new chemicals that directly inhibit the signal production and signal reception – so the bacteria can be more effectively killed by the host immune system.
This new concept is highly attractive because the spread of resistance seems highly unlikely. Firstly, resistant bacteria would not receive any signals from other bacteria as it sends and receives different signals. It would be similar to someone trying to speak Spanish to a room full of people speaking Russian, in no way does the Spanish speaker gain an advantage by not being able to interpret what is being said. This would mean the resistant bacteria would not be able to co-ordinate fundamental processes of infection, such as biofilm formation and protein production that inhibit our immune response.
Another potential solution is a naturally occurring diverse group of proteins known as antimicrobial peptides (AMP’s for short), which can kill not only bacteria but fungi and viruses too. These peptides are produced by almost all living organisms, with a purpose of killing any invading organisms. At first glance, they work in similar mechanisms to some antibiotics; by rupturing the membranes of pathogens and disrupting their foreign DNA, RNA or proteins.
Despite this, they have interesting properties that make them unique – the ability to recruit the host immune system to help fight infection. AMP’s are directly involved in the stimulation of chemicals which cause immune cells to move towards the site of infection. Another key advantage of these peptides is that they suppress the overactive inflammatory response that can cause sepsis. They do this by neutralizing pathogenic factors after they kill the bacteria, that would otherwise cause our body to injure its own tissue and organs.
Lastly, are bacteriophages (or phages for short). Phages are viruses that can target specific species of bacteria – and inject their DNA and burst the bacteria from the inside out. These viruses are biologically incompatible with any other organism and are unable to infect human cells, even leaving the ‘good’ bacteria alone in our body. However some bacteria can and do become resistant to phages, but potentially not for long. New research published in Scientific reports has identified a bacteriophage that can attack a specific protein exposed on the bacteria’s surface. What’s important about this protein – is that it’s also the protein that the bacteria uses to pump antibiotics out before they can do any damage. Now the bacteria is left with a choice; evolve to resist against the antibiotic, or the phage. In any case – it can’t be resistant to both.
The issue of antibiotic resistance concerns many – as many patients with cancer, HIV and other immuno-deficient diseases depend on antibiotics to keep them alive. More awareness is needed not only of the growing problem of antibiotic resistance but to further support the development of new treatments. We can only hope that some of the new and alternative treatments may bring an end to the issue of antibiotic resistance, once and for all.
Photo Credit: Creative Commons
Photo Comment: A photo of Phages
